ReviewESMO open2016
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015.
Review in ESMO open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 37 citations in OpenAlex.
- Extent of cancer at the time of diagnosis in older adults: a cohort of a Chilean cancer insurance program (2018-2022).Ecancermedicalscience · 2026Article
- Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis.JCO global oncology · 2024Article
- Global Equity in Clinical Trials: An ASCO Policy Statement.JCO global oncology · 2024Article
- Challenges and opportunities for sarcoma care and research in Latin America: a position paper from the LACOG sarcoma group.Lancet regional health. Americas · 2024Review
- Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023.Ecancermedicalscience · 2024Article
- Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.JCO global oncology · 2023Article
- Current Scenario of Clinical Cancer Research in Latin America and the Caribbean.Current oncology (Toronto, Ont.) · 2023Review
- Considerations and analysis of the implementation of oncogeriatrics in Chile and its importance: Review of current literature.Frontiers in aging · 2023Review
- Current scenario and future perspectives of clinical research in Brazil: a national survey.Ecancermedicalscience · 2023Article
- Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.Frontiers in oncology · 2023Article
- Identifying Priorities and Needs to Improve Oncology Research in the Gaza Strip, Palestine.Journal of multidisciplinary healthcare · 2023Article
- Priorities for cancer research in low- and middle-income countries: a global perspective.Nature medicine · 2022Review
- Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.Ecancermedicalscience · 2022Article
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.The Lancet. Oncology · 2021Review
- Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.The oncologist · 2019Review
- Precision oncology in Latin America: current situation, challenges and perspectives.Ecancermedicalscience · 2019Article
- Barriers in Latin America for the management of locally advanced breast cancer.Ecancermedicalscience · 2019Review
- Triple-negative breast cancer: the reality in Chile and in Latin America.Ecancermedicalscience · 2019Review
- Challenges in Lung Cancer Screening in Latin America.Journal of global oncology · 2018Review
- The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).Journal of experimental & clinical cancer research : CR · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 9 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Latin America and the Caribbean have not yet developed strong clinical cancer research programmes. In order to improve this situation two international cancer organisations, the Latin American Society of Clinical Oncology (SLACOM) and the European Society of Medical Oncology (ESMO) worked closely with the Peruvian Cooperative Oncology Group (GECOPERU) and organised a clinical cancer research workshop held in Lima, Peru, in October 2015. Many oncologists from different Latin American countries participated in this gathering. The opportunities for and strengths of clinical oncology research in Latin American and Caribbean countries were identified as the widespread use of the Spanish language, the high cancer burden, growing access to information, improving patient education, access to new drugs for research centres, regional networks and human resources. However, there are still many weaknesses and problems including the long timeline for regulatory approval, lack of economic investment, lack of training and lack of personnel participating in clinical research, lack of cancer registries, insufficient technology and insufficient supplies for the diagnosis and treatment of cancer, few cancer specialists, low general levels of education and the negative attitude of government authorities towards clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.